Cheng, S.-S., Jiang, J.-G., Lin, S.-C., Yu, Y.-H., Chang, T. W., Lim, C., Yu, Y.-B. and Chu, H.-M. (2020) “TE-1146, a novel anti-CD38-antibody-lenalidomide conjugate, demonstrates potent <i>ex vivo</i&gt; anti-myeloma activity”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288692.